VIR vs. VERU

Last updated Jun 3, 2026

VIR (Vir Biotechnology, Inc.) and VERU (Veru Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, VIR returned -28.26%/yr vs -51.59%/yr for VERU. At a 0.23 correlation, their price movements are largely independent.

Performance

VIR vs. VERU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vir Biotechnology, Inc. (VIR) and Veru Inc. (VERU). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VIR achieves a 44.94% return, which is significantly higher than VERU's 9.81% return.

VIR

• 1D: -3.21%
• 1M: -12.60%
• YTD: 44.94%
• 6M: 55.24%
• 1Y: 72.39%
• 3Y*: -31.58%
• 5Y*: -28.26%
• 10Y*: —

VERU

• 1D: -1.26%
• 1M: 3.98%
• YTD: 9.81%
• 6M: -0.42%
• 1Y: -59.28%
• 3Y*: -39.09%
• 5Y*: -51.59%
• 10Y*: -16.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VIR vs. VERU - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
VIR Vir Biotechnology, Inc.	44.94%	-17.85%	-27.04%	-60.25%	-39.55%	56.35%	112.96%	-10.31%
VERU Veru Inc.	9.81%	-67.10%	-9.65%	-86.36%	-10.36%	-31.91%	158.21%	61.84%

Correlation

The correlation between VIR and VERU is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.28
Correlation (3Y) Calculated over the trailing 3-year period	0.25
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (All Time) Calculated using the full available price history since Oct 14, 2019	0.23

Fundamentals

Market Cap VIR : $1.29B VERU : $50.89M
EPS VIR : -$3.14 VERU : -$0.78
PS Ratio VIR : 18.81 VERU : 137.99
PB Ratio VIR : 1.58 VERU : 1.46
Total Revenue (TTM) VIR : $65.50M VERU : $303.45K
Gross Profit (TTM) VIR : $183.11M VERU : -$57.90K
EBITDA (TTM) VIR : -$448.10M VERU : -$8.20M

Return for Risk

VIR vs. VERU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VIR

VIR Risk / Return Rank: 75
VIR Sharpe Ratio Rank: 72
VIR Sortino Ratio Rank: 73
VIR Omega Ratio Rank: 68
VIR Calmar Ratio Rank: 80
VIR Martin Ratio Rank: 80

VERU

VERU Risk / Return Rank: 11
VERU Sharpe Ratio Rank: 6
VERU Sortino Ratio Rank: 7
VERU Omega Ratio Rank: 8
VERU Calmar Ratio Rank: 11
VERU Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VIR vs. VERU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and Veru Inc. (VERU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VIR	VERU	Difference
Sharpe ratio Return per unit of total volatility	1.05	-0.89	+1.94
Sortino ratio Return per unit of downside risk	1.94	-1.27	+3.21
Omega ratio Gain probability vs. loss probability	1.22	0.84	+0.38
Calmar ratio Return relative to maximum drawdown	2.76	-0.77	+3.53
Martin ratio Return relative to average drawdown	6.85	-0.97	+7.81
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VIR vs. VERU - Sharpe Ratio Comparison

The current VIR Sharpe Ratio is 1.05, which is higher than the VERU Sharpe Ratio of -0.89. The chart below compares the historical Sharpe Ratios of VIR and VERU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	VIR	VERU	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.05	-0.89	+1.94
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.39	-0.40	+0.01
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.15	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.07	-0.07	0.00

Drawdowns

VIR vs. VERU - Drawdown Comparison

The maximum VIR drawdown since its inception was -94.85%, roughly equal to the maximum VERU drawdown of -99.12%. Use the drawdown chart below to compare losses from any high point for VIR and VERU.

Drawdown Indicators

	VIR	VERU	Difference
Max Drawdown Largest peak-to-trough decline	-94.85%	-99.12%	+4.27%
Max Drawdown (1Y) Largest decline over 1 year	-27.82%	-69.93%	+42.11%
Max Drawdown (3Y) Largest decline over 3 years	-84.32%	-88.32%	+4.00%
Max Drawdown (5Y) Largest decline over 5 years	-92.15%	-99.12%	+6.97%
Max Drawdown (10Y) Largest decline over 10 years	—	-99.12%	—
Current Drawdown Current decline from peak	-89.48%	-99.01%	+9.53%
Average Drawdown Average peak-to-trough decline	-67.55%	-54.02%	-13.53%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.24%	55.44%	-44.20%

Volatility

VIR vs. VERU - Volatility Comparison

Vir Biotechnology, Inc. (VIR) has a higher volatility of 16.12% compared to Veru Inc. (VERU) at 12.15%. This indicates that VIR's price experiences larger fluctuations and is considered to be riskier than VERU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VIR	VERU	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.12%	12.15%	+3.97%
Volatility (6M) Calculated over the trailing 6-month period	50.51%	36.99%	+13.52%
Volatility (1Y) Calculated over the trailing 1-year period	69.24%	68.29%	+0.95%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	72.77%	130.61%	-57.84%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	96.13%	109.00%	-12.87%

Dividends

VIR vs. VERU - Dividend Comparison

Neither VIR nor VERU has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VIR and VERU in my portfolio?

VIR and VERU have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VIR or VERU?

VIR has higher volatility (16.12%) compared to VERU (12.15%). In terms of maximum drawdown, VIR dropped -94.85% vs VERU's -99.12%.

Which has better risk-adjusted returns?

VIR currently has the higher Sharpe Ratio (1.05 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.